Wednesday, November 6, 2024

Veren Inc

ound bite for Twitter and StockTwits is: Dividend Paying Resource. Results of stock price testing is that the stock price is suggests that the stock price is relatively cheap. Debt Ratios are fine. The Dividend Payout Ratios (DPR) are currently good. The current dividend yield is good with dividend growth low to negative. See my spreadsheet on Veren Inc.

Is it a good company at a reasonable price? This is a resource stock and is therefore risky. It would also by cyclical. If you are buying for dividends, they be unstable. A positive is insider buying. Personally, I tend not be buy resource stocks, or buy them for a short hold. I never consider them a long term hold. If you like resource stocks currently, this is selling cheap.

I do not own this stock of Veren Inc (TSX-VRN, NYSE-VRN). I got this idea to look into this stock from another blogger, My Own Advisor and his November 2012 blog entry on great Canadian dividend paying stocks. I also noticed that several people at the Toronto Money Show of 2013 mentioned this stock.

When I was updating my spreadsheet, I noticed Crescent Point Energy Corp (TSX-CPG, NYSE-CPG) has changed its name and symbols to Veren Inc (TSX-VRN, NYSE-VRN) effective May 15. See news item on Newswire.

When I was updating my spreadsheet, I noticed that all the officers I follow, including CEO and CFO have increased their shares in the company and 2 of the 3 directors I follow have increased their shares in the company. These increases are over the past year.

If you had invested in this company in December 2013, for $1,031.25 you would have bought 25 shares at $41.25 per share. In December 2023, after 10 years you would have received $177.11 in dividends. The stock would be worth $229.75. Your total return would have been $406.86. This would be a total loss of 11.38% per year with 13.94% from capital loss and 2.57% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$41.25 $1,031.25 25 10 $177.11 $229.75 $406.86

Compared above with the last 5 years. If you had invested in this company in December 2018, for $1,001.28 you would have bought 242 shares at $4.14 per share. In December 2023, after 5 years you would have received $192.27 in dividends. The stock would be worth $2,223.98. Your total return would have been $2,416.25. This would be a total return of 19.52% per year with 17.29% from capital loss and 2.23% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$4.14 $1,001.88 242 5 $192.27 $2,223.98 $2,416.25

The current dividend yield is good with dividend growth low to negative. The current dividend yield is good (5% to 6% ranges) at 6.63%. The 5 year median dividend yield is low (below 1%) at 0.84%. The 10 year median dividend yield is moderate (2% to 4% ranges) at 2.95%. The historical median dividend yield is good at 6.96%.

The dividend growth over the past 5 years is low (below 8% per year) at 1.1% per year. However, this holds a lot of variations. Dividends were cut in 2019 by 89% and then another 75% in 2020. Dividends were rammed up in 2022 and the difference in dividends between 2021 and 2022 was an increase of 2833%. Dividends were increased in 2023 another 73%. The last dividend increase was for 15% and it was in 2024. Also, this company used to be an income trust which can have higher dividends than corporations. The company kept dividends flat for a number of years after the change to a corporation before decreasing dividends.

The Dividend Payout Ratios (DPR) are currently good. The DPR for 2023 for Earnings per Share (EPS) is good at 45% with 5 year coverage high at 72%. The DPR for 2023 for Adjusted Earnings per Share (AEPS) is good at 27% with 5 year coverage at 11%. The DPR for 2023 for Adjusted Funds from Operations (AFFO) is good at 9% with 5 year coverage at 5%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 12% with 5 year coverage at 5%. The DPR for 2023 for Free Cash Flow (FCF) is good at 22% with 5 year coverage at 14%.

Item Cur 5 Years
EPS 44.90% 72.23%
AEPS 27.47% 11.32%
AFFO 8.91% 5.05%
CFPS 12.86% 5.25%
FCF 21.73% 13.82%

Debt Ratios are fine. The Long Term Debt/Market Cap Ratio for 2023 is fine at 0.66 and currently at 0.59. The Liquidity Ratio for 2023 is too low at 0.76 and 1.29 currently. If you added in Cash Flow after dividends, the ratios are fine at 2.15 and currently at 2.92. The Debt Ratio for 2023 is good at 2.16 and 2.23 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.53 and 0.86 and currently at 1.82 and 0.82.

Type Year End Ratio Curr
Lg Term R 0.66 0.59
Intang/GW 0.05 0.05
Liquidity 0.76 1.29
Liq. + CF 2.15 2.92
Liq. CF. DB 2.97 4.19
Debt Ratio 2.16 2.23
Leverage 1.86 1.82
D/E Ratio 0.86 0.82

The Total Return per year is shown below for years of 5 to 22 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 1.09% 19.52% 17.29% 2.33%
2013 10 -17.99% -11.38% -13.94% 2.57%
2008 15 -11.99% 3.06% -6.22% 9.28%
2003 20 -2.87% 16.11% -1.81% 17.92%
2001 22 37.53% 4.39% 33.14%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 0.74, 1.19 and 1.64. The corresponding 10 year ratios are negative and unusable. The corresponding historical ratios are 2.88, 6.20 and 9.52. The current P/E Ratio is 19.50 based on a stock price of $7.45 and EPS estimate for 2024 of $0.38. The ratio is way above the 5 year ratios, which are very low due to earnings losses. However, a ratio is 19.50 is on the high side.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 04.26, 6.11 and 7.96. The corresponding 10 year ratios are 6.86, 12.39 and 14.98. The current P/AEPS Ratio is 4.84 based on a stock price of $7.45 and AEPS estimate for 2024 of $1.54. The current ratio is below the low ratio for the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Adjusted Funds from Operations (AFFO) data. The 5-year low, median, and high median Price/ Adjusted Funds from Operations Ratios 1.18, 2.17 and 2.71. The corresponding 10 year ratios are 1.86, 2.54 and 3.55. The current P/AFFO Ratio is 2.06 based on a stock price of $7.45 and AFFO estimate for 2024 of $3.62. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $17.87. The 10-year low, median, and high median Price/Graham Price Ratios are 0.37, 0.64 and 0.82. The current P/GP Ratio is 0.42 based on a stock price of $7.45. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Book Value per Share Ratio of 0.79. The current P/B Ratio is 0.81 based on a Book Value of $6,868M, Book Value per Share of $11.08 and a stock price of $7.45. The current ratio is 2% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 2.68. The current P/CF Ratio is 1.99 based on a stock price of $7.45, Cash Flow per Share estimate for 2024 of $3.74 and a Cash Flow of $2,315M. The current ratio is 26% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 6.96%. The current dividend yield is 6.17% based on dividends of $0.46 and a stock price of $7.45. The current yield is 11% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. Since this company used to be an income trust with high dividend yields, this would not be a good test.

I get a 10 year median dividend yield of 2.95%. The current dividend yield is 6.17% based on dividends of $0.46 and a stock price of $7.45. The current yield is 109% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 1.37. The current P/S Ratio is 1.09 based on a stock price of $7.45, Revenue estimate for 2024 of $4,224 and Revenue per Share of $6.81. The current ratio is 20.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is suggests that the stock price is relatively cheap. The 10 year dividend yield is saying that the stock price is cheap. This is confirmed by the P/S Ratio test. The rest of the testing says that the stock price is cheap or reasonable.

When I look at analysts’ recommendations, I find Strong Buy (8), Buy (5), and Hold (1). The consensus would be a Strong Buy. The 12 months stock price consensus is $11.82 with a high of $14.00 and low of $10.00. The consensus stock price of $11.82 implies a total return of 64.83 with 58.66% from capital gains and 6.17% from dividends based on a current stock price of $7.45.

There are lots of analyst comments on Stock Chase for this stock. Most are positive. However, one analyst said that there were better names elsewhere. Stock Chase gives this stock 4 stars out of 5. Jitendra Parashar on Motley Fool says Canadian Stocks are decline with this stock tanking. Rajiv Nanjapla on Motley Fool in December 2023 felt this stock could give you superior long term returns. The company put out a press release via Newswire about their fourth quarter results for 2023. The company put out a Press Release about their third quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street gives this stock 3 and one half stars out of 5. They have 4 warnings out on this stock of earnings are forecast to decline by an average of 2.4% per year for the next 3 years; shareholders have been diluted in the past year; has a high level of debt; and unstable dividend track record.

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada. Its web site is here Veren Inc.

The last stock I wrote about was about was Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more. The next stock I will write about will be Finning International Inc (TSX-FTT, OTC-FINGF) ... learn more on Friday, November 8, 2024 around 5 pm. Tomorrow on my other blog I will write about Something to Buy November 2024.... learn more on Thursday, November 7, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, November 4, 2024

Innergex Renewable Energy

Sound bite for Twitter and StockTwits is: Dividend Paying Utility. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are generally awful and debt it way too high. The Dividend Payout Ratios (DPR) are only positive for Cash Flow, but are really showing that dividends are not well covered. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Innergex Renewable Energy.

Is it a good company at a reasonable price? This stock is probably cheap, but that does not make it a good buy. Dividends were recently cut. The company is not expected to have much in earnings anytime soon. Personally, I like companies that have earnings and increasing dividends. It was probably wise for the company to cut their dividends. This is not the sort of company I would be interested in.

I do not own this stock of Innergex Renewable Energy (TSX-INE, OTC-INGXF). In 2006 I bought Innergex Power on a buy rating and favorable report from TD although it has only been going from 2003. In 2008 I sold Innergex as I did not think that it is a stock I want to hold as dividend increased less than the rate of inflation.

When I was updating my spreadsheet, I noticed that there has been little growth over the past 5 and 10 years for this stock. You have a bit of Revenue growth and some Stock Price growth and that is it. See below.

In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth expected over 12 months to the first quarter in 2024 and expected growth over this year.

Yr Item Tot. Gwth Per Year Gwth Coverage
5 Revenue Growth 68.20% 10.96% 1.30% <-12 mths
5 AEPS Growth -104.76% N/C -1200.00% <-12 mths
5 Net Income Growth -401.15% N/C -26.83% <-12 mths
5 Cash Flow Growth 42.25% 7.30% -13.89% <-12 mths
5 Dividend Growth 6.67% 1.30% -37.50% <-12 mths
5 Stock Price Growth -26.71% -6.03% 3.48% <-12 mths
10 Revenue Growth 389.20% 17.21% 7.02% <-this year
10 AEPS Growth -102.33% N/C -1700.00% <-this year
10 Net Income Growth -316.70% N/C -78.47% <-this year
10 Cash Flow Growth 143.57% 9.31% -9.83% <-this year
10 Dividend Growth 24.14% 2.19% -50.00% <-this year
10 Stock Price Growth -13.30% -1.42% 30.58% <-this year

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 4.04%. The 5 and 10 year median dividend yields are also moderate at 4.14% and 4.76%. The historical median dividend yield is good (5% to 6% ranges) at 5.74%. This company used to be an income trust and these companies have much higher dividend yields than corporations. Dividend did drop when this company became a corporation. The dividends are increase at a low rate (below 8% per year) at 1.30% per year over the past 5 years. The last dividend change was in 2024 and dividends were decreased by 50%.

The Dividend Payout Ratios (DPR) are only positive for Cash Flow, but are really showing that dividends are not well covered. The DPR for 2023 for Earnings per Share (EPS) is cannot be calculated because of earning losses. The DPR for 2023 for Adjusted Earnings per Share (AEPS) cannot be calculated because of Adjusted EPS losses with 5 year coverage high at 109%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 24% with 5 year coverage at 32%. The DPR for 2023 for Free Cash Flow (FCF) is not valid because both the FCF is negative. There is no agreement on what the FCF is, but all say it is negative.

Item Cur 5 Years
EPS N/C N/C
AEPS N/C 109.15%
CFPS 24.40% 31.65%
FCF -38.53% -165.93%

Debt Ratios are generally awful and debt it way too high. The Long Term Debt/Market Cap Ratio for 2023 is very high at 3.21and currently at 2.93. Investors do not seem to think that the The Liquidity Ratio for 2023 is good at 1.55 and 1.50 currently. If you added in Cash Flow after dividends, the ratios are fine at 1.53 and currently at 1.76. The Debt Ratio for 2023 is good at 1.68 and 1.68 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.47 and 0.47 and currently at 1.46 and 0.46.

Type Year End Ratio Curr
Lg Term R 3.21 2.93
Intang/GW 0.77 0.72
Liquidity 0.91 0.57
Liq. + CF 0.56 0.75
Liq. CF DB 2.45 2.29
Debt Ratio 1.16 1.19
Leverage 7.42 6.14
D/E Ratio 6.42 5.14

The Total Return per year is shown below for years of 5 to 20 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 1.30% 0.39% -6.03% 6.42%
2013 10 2.19% 5.26% -1.42% 6.67%
2008 15 0.33% 11.27% 2.55% 8.72%
2003 20 0.72% 8.02% 0.52% 7.49%

The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and useless. The corresponding 10 year ratios are also negative and useless. The corresponding historical ratios are negative and useless. I can do not stock price testing here.

I also have Adjusted Earnings per Share (AEPS) data. However, the 10 year P/AEPS Ratios are negative and useless. There are 10 year ratios, but they are very high. The current ratio is negative because the AEPS is expected to be negative again this year. I can do not stock price testing here.

Because the EPS and AEPS are negative, I cannot do any Graham Price testing.

I get a 10-year median Price/Book Value per Share Ratio of 3.81. The current P/B Ratio is 1.35 based on a Book Value of $1,339M, Book Value per Share of $6.58 and a stock price of $8.92. The current ratio is 62% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I also have a Book Value per Share estimate for 2024 of $4.06. This implies a ratio of 2.20 based on a stock price of $8.92 and Book Value of $826M. This ratio is 23% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get a 10-year median Price/Cash Flow per Share Ratio of 10.52. The current ratio is 6.76 based on Cash Flow per Share estimate for 2024 of $1.32, Cash Flow of $269M and a stock price of $8.92. The current ratio is 36% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 5.74%. The current dividend yield is 4.04% based on dividends of $0.36 and a stock price of $8.92. The current dividend yield is 30% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively expensive. The problem with this test is that dividends have recently been cut.

I get a 10 year median dividend yield of 4.76%. The current dividend yield is 4.04% based on dividends of $0.36 and a stock price of $8.92. The current dividend yield is 15% below the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. The problem with this test is that dividends have recently been cut.

The 10-year median Price/Sales (Revenue) Ratio is 4.26. The current P/S Ratio is 1.75 based on Revenue estimate for 2024 of $1,038M, Revenue per Share of $5.10 and a stock price of $8.92. The current ratio is 63% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably cheap. The 10 year dividend yield test says that the stock price is reasonable, but above the median. However, the dividends were recently cut. This is, of course, a bad sign. The P/S Ratio testing is saying that the stock price is relatively cheap. Since the stock has not much in the way of earnings, testing for earnings cannot be done. Other testing I can do shows that the stock price is relatively cheap.

When I look at analysts’ recommendations, I find Buy (4), and Hold (5). The consensus would be a Buy. The 12 months consensus stock price is $12.00 with a high of $17.00 and low of $10.00. The consensus stock price of $12.00 implies a total return of 38.57% with 34.53% from capital gains and 4.04% from dividends based on a current stock price of $8.92.

There are few analysts on Stock Chase following this stock. In past years there were Do Not Buy recommendations. The worries are operating weakness and high debt. Stock Chase gives this stock 3 stars out of 5. Adam Othman on Motley Fool thinks you should buy this stock as it is incredibly cheap. Amy Legate-Wolfe on Motley Fool also thinks you should be buy this because it is cheap. The company put out a press release via Newswire on their fourth quarter of 2024 results. The company put out a press release via Newswire about their second quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. They have two warnings of dividend of 3.96% is not well covered by earnings or free cash flows; and has less than 1 year of cash runway. Simply Wall Street gives this stock 2 and one half stars out of 5.

Innergex Renewable Energy Inc is an independent Canadian renewable power producer. It develops, acquires, owns, and operates hydroelectric, wind, and solar facilities in Canada, the United States, France, and Chile. Its web site is here Innergex Renewable Energy.

The last stock I wrote about was about was Johnson and Johnson (NYSE-JNJ) ... learn more. The next stock I will write about will be Veren Inc (TSX-VRN, NYSE-VRN) ... learn more on Wednesday, November 6, 2024 around 5 pm. Tomorrow on my other blog I will write about Dividend Stocks November 2024 learn more on Tuesday, November 5, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Friday, November 1, 2024

Johnson and Johnson

Sound bite for Twitter and StockTwits is: Dividend Growth Consumer. Results of stock price testing is that the stock price is pointing to a reasonable price that is below the median. Debt Ratios are fine, but Liquidity Ratio is low. The Dividend Payout Ratios (DPR) are fine. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Johnson and Johnson.

Is it a good company at a reasonable price? This stock is part of the US Dividend Aristocrats and with its shareholders have received increasing dividends over a long period of time. It has not been a great performer over time, but it has been an acceptable one. If you buy US stocks, you should really use a US$ account so you can move money into and out of US$ when you chose. The problem with the TSX is that there are few Health Care stocks to chose from and this is a Health Care stock. People buy Health Care stocks for diversification. The stock price seems reasonable at this time.

I do not own this stock of Johnson and Johnson (NYSE-JNJ). As Canadians, we are told we should be buying US stocks for our portfolio. It is often recommended that we have at least 25% of our portfolio in US stocks. I have never followed this, although I have tried dipping into the US market, but I have never made any money there. I bought some of this stock in June 2005 and realized a year later, in June of 2006 that it was going nowhere for me and sold. I lost almost 17% of my investment. When I bought in 2005, all the analysts were saying that it was a good buy at that time.

When I was updating my spreadsheet, I noticed both EPS and Net Income went up a lot in 2023 because of earnings from discontinued operations. They are expected to go closer to values of 2022 in 2024. For example, EPS climbed 104% in 2023 and is expected to go down by 47% in 2024. However, the EPS expected in 2024 is 7% higher than in 2022. Also, Revenue went down in 2023 because of the spin-off of Kenvue. See the Press Release. Revenue was down by 10% in 2023 and is expected to rise by 4% in 2024.

If you had invested in this company in December 2013, for $1,007.47 you would have bought 11 shares at $91.59 per share. In December 2023, after 10 years you would have received $404.69 in dividends. The stock would be worth $1,724.14. Your total return would have been $2,128.83. This would be a total return of 8.63% per year with 5.52% from capital gain and 3.11% from dividends. This is buying the stock in the US market using a US$ account.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$91.59 $1,007.49 11 10 $404.69 $1,724.14 $2,128.83

The current dividend yield is moderate (2% to 4% ranges) at 3.09%. The 5, 10 and historical median dividend yields are also moderate at 2.76%, 2.79% and 2.46%. The dividend increases for the last 5 years is low (less than 8% per year) at 5.8% per year. The last dividend increase was for 4.2% and it occurred in 2024.

The Dividend Payout Ratios (DPR) are fine. The DPR for 2023 for Earnings per Share (EPS) is good at 34% with 5 year coverage at 53%. The DPR for 2023 for Adjusted Earnings per Share (AEPS) is good at 47% with 5 year coverage at 45%. The DPR for 2023 for Cash Flow per Share (CFPS) is fine at 56% with 5 year coverage at 48%, but I prefer the rate to be 40% or less. The DPR for 2023 for Free Cash Flow (FCF) is fine at 65% with 5 year coverage at 58%.

Item Cur 5 Years
EPS 34.26% 53.48%
AEPS 47.38% 45.35%
CFPS 55.77% 47.96%
FCF 64.50% 57.59%

Debt Ratios are fine, but Liquidity Ratio is low. The Long Term Debt/Market Cap Ratio for 2023 is good at 0.07 and currently at 0.08. The Liquidity Ratio for 2023 is too low at 1.16 and 1.03 currently. If you added in Cash Flow after dividends, the ratios are still low at 1.40 and currently at 1.27. I prefer these ratios to be at 1.50 or higher. The Debt Ratio for 2023 is good at 1.70 and 1.65 currently. The Leverage and Debt/Equity Ratios for 2023 are fine at 2.44 and 1.44 and currently at 2.54 and 1.54.

Type Year End Ratio Curr
Lg Term R 0.07 0.08
Intang/GW 0.19 0.22
Liquidity 1.16 1.03
Liq. + CF 1.40 1.27
Debt Ratio 1.70 1.65
Leverage 2.44 2.54
D/E Ratio 1.44 1.54

The Total Return per year is shown below for years of 5 to 35 to the end of 2023 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 6.03% 6.97% 3.96% 3.01%
2013 10 6.37% 8.63% 5.52% 3.11%
2008 15 6.97% 9.93% 6.63% 3.30%
2003 20 8.99% 8.73% 5.81% 2.92%
1998 25 9.85% 7.90% 5.42% 2.49%
1993 30 10.50% 12.86% 9.19% 3.67%
1988 35 11.21% 14.12% 10.15% 3.97%

The Total Return per year is shown below for years of 5 to 35 to the end of 2023 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 5.18% 6.24% 3.32% 2.92%
2013 10 8.48% 11.32% 7.84% 3.47%
2008 15 7.18% 10.29% 7.18% 3.11%
2003 20 8.59% 8.59% 5.94% 2.66%
1998 25 10.61% 6.94% 4.77% 2.17%
1993 30 10.22% 12.70% 9.17% 3.54%
1988 35 11.47% 14.75% 10.57% 4.18%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 20.17, 24.17, and 26.01. The corresponding 10 year ratios are 19.88, 22.55 and 24.50. The corresponding historical ratios are 16.55, 19017 and 21.97. The current ratio is 22.29 based on a stock price of $160.61 and EPS estimate for 2024 of $7.20. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Earnings per Share (AEPS) data. The 5-year low, median, and high median Price/Adjusted Earnings per Share Ratios are 14.68, 16.72 and 18.31. The corresponding 10 year ratios are 14.62, 16.39 and 18.24. The corresponding 10 year ratios are 19.88, 22.55 and 24.50. The current ratio is 16.14 based on a stock price of $160.61 and AEPS estimate for 2024 of $9.95. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $80.78. The 10-year low, median, and high median Price/Graham Price Ratios are 1.83, 2.04 and 2.26. The current ratio is 1.99 based on a stock price of $160.61. This ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median. I get a 10-year median Price/Book Value per Share Ratio of 5.70. The current P/B Ratio is 5.51 based on a Book Value of $70,158M, Book Value per Share of $29.15 and a stock price of $160.61. The current ratio is 3% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have a Book Value per Share estimate for 2024 of $30.08. This implies a P/B Ratio of 5.34 with a Book Value of $72,405M, and a stock price of $160.61. This ratio is 6% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 15.77. The current P/CF Ratio is 15.75 based on Cash Flow per Share estimate for 2024 of $10.20, Cash Flow of $24,552M and a stock price of $160.61. The current ratio is 0.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 2.46%. The current dividend yield is 3.09% based on dividends of $4.96 and stock price of $160.61. The current dividend yield is 26% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get a 10 year median dividend yield of 2.79%. The current dividend yield is 3.09% based on dividends of $4.96 and stock price of $160.61. The current dividend yield is 10% above the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively reasonable and below the median.

The 10-year median Price/Sales (Revenue) Ratio is 4.36. the current P/S Ratio is 4.35 based on Revenue estimate for 2024 of $88,786M, Revenue per Share of $36.89 and a stock price of $160.61. The current ratio is 0.2% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median. Results of stock price testing is that the stock price is pointing to a reasonable price that is below the median. The 10 year dividend yield test says that the stock price is reasonable and below the median. The P/S Ratio test confirms this. Practically all the testing is saying the same thing.

When I look at analysts’ recommendations, I find Strong Buy (7), Buy (3), and Hold (13). The consensus would be a Buy. The 12 months consensus stock price is $174.28 with a high of $215.00 and low of $155.00. The 12 month stock price of $174.28 implies a total return of 11.60% with 8.51% from capital gains and 3.09% from dividends based on a current stock price of $160.61.

Some analysts on Stock Chase like this stock and think it is a buy and other do not like it. Mainly it is not liked because of disappointing results and because Healthcare is a tough business. Stock Chase gives this company 5 stars out of 5. Tony Dong on Motley Fool thinks you should buy this stock as it has increased its dividends for over 50 consecutive years. Kay Ng on Motley Fool thinks you should own this conservative stock in your RRSP. The company put out a Press Release about their fourth quarter of 2023. The company put out a Press Release about their third quarter of 2024.

There is a Bloomberg report on Yahoo Finance about the Talc Court case. Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street has one warning on this stock of large one-off items impacting financial results. This is why your have Adjusted Earnings per Share.

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, and medical devices divisions. They sold off their consumer products divisions. Its web site is here Johnson and Johnson.

The last stock I wrote about was about was Cenovus Energy Inc (TSX-CVE, NYSE-CVE) ... learn more. The next stock I will write about will be Innergex Renewable Energy (TSX-INE, OTC-INGXF) ... learn more on Monday, November 4, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Wednesday, October 30, 2024

Cenovus Energy Inc

Sound bite for Twitter and StockTwits is: Dividend Paying Resource. Results of stock price testing is that the stock price is probably reasonable and could be cheap. Debt Ratios are good. The current dividend yield is moderate with dividend growth currently high after a dividend cut. The Dividend Payout Ratios (DPR) are good. See my spreadsheet on Cenovus Energy Inc.

Is it a good company at a reasonable price? This is an energy stock and so it is risky. If you look at a chart for this stock, its price is relatively high compared to the past. Money Sense just added this stock to its dividend list this year. Analysts seem to think that will do well in the future. My testing is showing that the stock price is probably reasonable, and the dividend yield testing is showing it is cheap.

I do not own this stock of Cenovus Energy Inc (TSX-CVE, NYSE-CVE) I do not own this stock of Cenovus Energy but I used to. I had held this stock previously as Alberta Energy Company from April 2000 until August 2002 and made some 18% total returns per year.

This is another stock that was talked about at the 2010 Money Show in Toronto. There were those who liked oil companies and they mentioned both Suncor Energy Inc. (TSX-SU) and Cenovus Energy Inc. (TSX-CVE). This company was split off from EnCana (TSX-ECA) in 2009. My spreadsheet reflects this split. I was also following Alberta Energy Co. (TSX-AEC) into EnCana.

When I was updating my spreadsheet, I noticed that this company is doing better this year that last year. Last year Revenue was down 23%, but it is up 11% so far this year. EPS was down by 34% in 2023, but are up by 18% so far this year. Cash Flow was down in 2023 by 35%, but is up by 41% so far this year.

If you had invested in this company in December 2013, for $1,003.20 you would have bought 33 shares at $30.40 per share. In December 2023, after 10 years you would have received $159.61 in dividends. The stock would be worth $884.40. Your total return would have been $1,044.01. This would be a total return of 0.09% per year with 1.25% from capital loss and 1.35% from dividends.

Cost Tot. Cost Shares Years Dividends Stock Val Tot Ret
$30.40 $1,003.20 33 11 $159.61 $884.40 $1,044.01

The current dividend yield is moderate with dividend growth currently high after a dividend cut. The current dividend yield is moderate (2% to 4% ranges) at 3.14%. The 5, 10 and historical dividend yields are low (below 2%) at 1.48%, 1.60% and 1.47%. The dividend growth over the past 5 years is good at 21.3% per year. However, dividends were cut in 2015 by 81%, and are still some 32% below the dividends given in 2014. The last dividend increase was in 2024 and it was for 28.6%. It was recently put on the Money Sense Dividend list. I have data for the past 31 years and dividends have gone up 14 times and down 6 times over this period.

The Dividend Payout Ratios (DPR) are good. The DPR for 2023 for Earnings per Share (EPS) is good at 25% with 5 year coverage at 25%. The DPR for 2023 for Funds from Operations (FFO) is good at 22% with 5 year coverage at 7%. The DPR for 2023 for Cash Flow per Share (CFPS) is good at 11% with 5 year coverage at 8%. The DPR for 2023 for Free Cash Flow (FCF) is good at 28% with 5 year coverage at 15%. But here again, there is no agreement on FCF.

Item Cur 5 Years
EPS 24.76% 24.89%
FFO 22.44% 7.15%
CFPS 11.36% 7.93%
FCF 28.39% 14.55%

Debt Ratios are good. The Long Term Debt/Market Cap Ratio for 2023 is good at 0.12 and currently at 0.17. The Liquidity Ratio for 2023 is good at 1.56 and 1.66 currently. The Debt Ratio for 2023 is good at 2.14 and 2.16 currently. The Leverage and Debt/Equity Ratios for 2023 are good at 1.88 and 0.88 and currently at 1.87 and 0.87.

Type Year End Ratio Curr
Lg Term R 0.12 0.17
Intang/GW 0.06 0.07
Liquidity 1.56 1.66
Liq. + CF 2.59 2.76
Debt Ratio 2.14 2.16
Leverage 1.88 1.87
D/E Ratio 0.88 0.87

The Total Return per year is shown below for years of 5 to 31 to the end of 2023 in CDN$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 21.29% 24.46% 22.79% 1.67%
2013 10 -5.93% 0.09% -1.25% 1.35%
2008 15 -3.88% 1.87% -0.21% 2.08%
2003 20 7.42% 6.94% 3.90% 3.03%
1998 25 8.65% 10.10% 6.59% 3.51%
1993 30 7.64% 10.99% 7.51% 3.48%
1992 31 7.38% 11.22% 7.71% 3.51%

The Total Return per year is shown below for years of 5 to 18 to the end of 2023 in US$. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div.
2018 5 22.04% 20.68% 18.82% 1.86%
2013 10 -7.96% -3.99% -5.28% 1.29%
2008 15 -4.38% 0.46% -2.01% 2.47%
2005 18 7.29% 1.05% -1.52% 2.57%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 5.64, 7.38 and 9.67. The corresponding 10 year ratios are 5.36, 7.07 and 8.77. The corresponding historical ratios are 12.09, 14.37 and 16.52. The current ratio is 10.31 based on a stock price of $22.93 and EPS for 2024 of $2.22. The current ratio is above the high ratio of the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive. However, normally a P/E Ratio is 10.31 is considered a low ratio.

I also have Adjusted Funds from Operations (AFFO) data. The 5-year low, median, and high median Price/ Adjusted Funds from Operations Ratios are 3.34, 4.32 and 5.66. The corresponding 10 year ratios are 4.36, 5.73 and 7.65. The current P/AFFO is 4.67 based on a stock price of $22.93 and AFFO estimate for 2024 of $4.91. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Funds from Operations (FFO) data. The 5-year low, median, and high median Price/ Funds from Operations Ratios are 4.49, 5.93 and 7.11. The corresponding 10 year ratios are 4.72, 6.22 and 8.14. The current P/FFO is 9.76 based on a stock price of $22.93 and FFO estimate for 2024 of $2.35. The current ratio is above the high ratio for the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a Graham Price of $28.32. The 10-year low, median, and high median Price/Graham Price Ratios are 0.51, 0.80 and 1.02. The current P/GP Ratio is 0.81 based on a stock price of $22.93. The current ratio is between the median and high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 1.17. The current P/B Ratio is 1.43 based on a stock price of $22.93, Book Value of $30.012M and Book Value per Share of $16.03. The current ratio is 22% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I also have a Book Value per Share estimate for 2024 of $16.44. This implies a P/B Ratio of 1.39 and a Book Value of $30,774M. This ratio is 19% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Cash Flow per Share Ratio of 6.11. The current P/CF Ratio is 4.74 based on Cash Flow per Share estimate for 2024 of $4.84, Cash Flow of $9,054 and a stock price of $22.93. The current ratio is 22% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 1.47%. The current dividend yield is 3.14% based on dividends of $0.72 and stock price of $22.93. The current yield is 114% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

I get an historical median dividend yield of 1.60%. The current dividend yield is 3.14% based on dividends of $0.72 and stock price of $22.93. The current yield is 97% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.

The 10-year median Price/Sales (Revenue) Ratio is 0.81. The current ratio is 0.74 based on Revenue estimate for 2024 of $58,050M, Revenue per Share of $31.01 and a stock price of $22.93. The current ratio is 9% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.

Results of stock price testing is that the stock price is probably reasonable and could be cheap. The dividend yield testing is saying that the stock price is relatively cheap. The P/S Ratio testing is saying that the stock price is reasonable and below the median. The rest of the testing is mixed with results from cheap to expensive.

When I look at analysts’ recommendations, I find Strong Buy (10), Buy (10). The consensus would be a Strong Buy. The 12 month stock price consensus is $31.75 with a high of $38.00 and low of $29.00. The consensus of $31.75 implies a total return of 41.60% with 38.46% from capital gains and 3.14% from dividends based on a current stock price of $22.93.

There is lots of coverage on Stock Chase for this stock. Most recommendations are buys, but there are a few that say that they like other companies better. Stock Chase gives this stock 5 stars out of 5. Aditya RaghunathMotley Fool reviews this stock. He thinks it is cheap, but this stock has always underperformed the market. Chris MacDonald on Motley Fool reviews this stock. Her thinks it is currently a buy. The company put out a Press Release on its fourth quarter for 2023. The company put out a Press Release about its second quarter of 2024.

Insider Money via Yahoo Finance put out a report on this stock and said it was a profitable Value stock to invest in. Simply Wall Street via Yahoo Finance talks about who owns this company. It says that institutions own more than half the company. Simply Wall Street has two warnings on this company of earnings are forecast to decline by an average of 1.2% per year for the next 3 years; and unstable dividend track record. Simply Wall Street gives this stock 4 stars out of 5.

Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. Its web site is here Cenovus Energy Inc.

The last stock I wrote about was about was Keyera Corp (TSX-KEY, OTC-KEYUF) ... learn more. The next stock I will write about will be Johnson and Johnson (NYSE-JNJ) ... learn more on Friday, November 1, 2024 around 5 pm. Tomorrow on my other blog I will write about Annuities .... learn more on Thursday, October 30, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.

Monday, October 28, 2024

Keyera Corp

Sound bite for Twitter and StockTwits is: Dividend Growth Utility. Results of stock price testing is that the stock price is probably reasonable, but could be cheap. Debt Ratios show that the company has too much debt, but the Liquidity Ratio is fine. The Dividend Payout Ratios (DPR) are fine. The current dividend yield is moderate with dividend growth low. See my spreadsheet on Keyera Corp.

Is it a good company at a reasonable price? This stock is Utility Energy stock. If you look at the chart for the last 12 year, the stock price is relatively high. You should expect volatility because the stock is part of the energy business. It has a high level of debt, but most utility companies do. Mostly this stock has done well by its shareholders, but initial purchase price seems to count. My testing is showing that the stock price could be still reasonable.

I do not own this stock of Keyera Corp (TSX-KEY, OTC-KEYUF). I started to review some of the stock recommended by Jennifer Dowty from a column she wrote and I reviewed in February 2010 on Dividends and Special Dividends. The title of the article in Investor’s Digest was Dividend Stocks: Buy, Hold and Collect. Jennifer is now works for the Globe and Mail. Jennifer worked as a Portfolio Manager for Manulife Asset Management Limited after working for Investor's digest.

When I was updating my spreadsheet, I noticed they have not had a very good start to this year with Revenue, AFFO, and Net Income all down. For this year, analysts expect Revenue, AFFO, and Cash Flow to decrease. In the chart below, I am showing 5 and 10 year total growth and per year growth in columns 3 and 4. Column 5 shows growth expected over 12 months to the first quarter in 2024 and expected growth over this year.

Yr Item Tot. Gwth Per Year Gwth Coverage
5 Revenue Growth 57.96% 9.57% -0.71% <-12 mths
5 AFFO Growth 21.10% 3.90% -3.22% <-12 mths
5 Net Income Growth 7.56% 1.47% -19.72% <-12 mths
5 Cash Flow Growth 61.42% 10.05% 12.67% <-12 mths
5 Dividend Growth 13.95% 2.65% 4.08% <-12 mths
5 Stock Price Growth 24.10% 4.41% 37.43% <-12 mths
10 Revenue Growth 115.22% 7.97% -2.17% <-this year
10 AFFO Growth 102.72% 7.32% -5.36% <-this year
10 Net Income Growth 188.78% 11.19% 20.91% <-this year
10 Cash Flow Growth 153.31% 9.74% -1.34% <-this year
10 Dividend Growth 75.00% 5.76% 4.49% <-this year
10 Stock Price Growth 0.20% 0.02% 37.43% <-this year

In the following chart, I am showing Capital Gains and Total Return against the starting values for P/E Ratio, P/S Ratio and Dividend yield. On the 10 year Capital Gain and Total Return is low and the starting P/E Ratio was relatively high and the Dividend Yield relatively low compared to other years. So, maybe for this stock we should look closely at the P/E Ratio and Dividend Yield to determine if price is relatively good or not.

# Years Cap. Gain Total Ret Beg P/E Beg P/S Beg Yield
5 4.41% 11.24% 16.43 2.05 5.41%
10 0.02% 5.26% 28.95 1.89 3.09%
15 8.98% 18.30% 10.69 1.04 7.36%
20 8.51% 17.61% 26.16 1.05 7.57%
current 19.42 1.42 4.77%

The current dividend yield is moderate with dividend growth low. The current dividend yield is moderate (2% to 4% ranges) at 4.82%. The 5, 10 and historical median dividend yields are good (5% and 6% ranges) a t6.26%, 5.68% and 6.02%. The 5 year dividend yield is low (below 8% per year) at 2.7% per year over the past 5 years. The last dividend increase was this year and it was for 4%. This used to be an income trust and all these companies are having a hard time getting dividends right after becoming corporations.

The Dividend Payout Ratios (DPR) are fine. The DPR for 2023 for Earnings per Share (EPS) is very high at 106% with 5 year coverage at 134%. The DPR for 2023 for Adjusted Funds from Operations (AFFO) is good at 52% with 5 year coverage at 61%. The DPR for 2023 for Cash Flow per Share (CFPS) is fine, but a bit high at 43% with 5 year coverage at 51%. I prefer this to be 40% or less. The DPR for 2023 for Free Cash Flow (FCF) is too high at 178% with 5 year coverage at 828%. However, these is no agreement on what the FCF is.

Item Cur 5 Years
EPS 105.95% 133.71%
AFFO 52.55% 60.74%
CFPS 43.71% 51.26%
FCF 177.95% 827.66%

Debt Ratios show that the company has too much debt, but the Liquidity Ratio is fine. The Long Term Debt/Market Cap Ratio for 2023 is fine at 0.53 and good currently at 0.38. The Liquidity Ratio for 2023 is low at 1.34 and 1.30 currently. If you added in Cash Flow after dividends, the ratios are fine at 2.00 and currently at 1.87. The Debt Ratio for 2023 is fine at 1.46 and 1.46 currently. I would prefer this to be at 1.50 or higher. The Leverage and Debt/Equity Ratios for 2023 are too high at 3.16 and 2.16 and currently at 3.16 and 2.16. I prefer them to be below 3.00 and 2.00

Type Year End Ratio Curr
Lg Term R 0.53 0.38
Intang/GW 0.01 0.01
Liquidity 1.34 1.30
Liq. + CF 2.00 1.87
Debt Ratio 1.46 1.46
Leverage 3.16 3.16
D/E Ratio 2.16 2.16

The Total Return per year is shown below for years of 5 to 21 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.

From Years Div. Gth Tot Ret Cap Gain Div. check
2018 5 2.65% 11.24% 4.41% 6.83% 11.24%
2013 10 5.76% 5.26% 0.02% 5.24% 5.26%
2008 15 5.90% 18.30% 8.98% 9.32% 18.30%
2003 20 10.37% 17.61% 8.51% 9.10% 17.61%
2002 21 18.78% 9.25% 9.54% 18.78%

The 5-year low, median, and high median Price/Earnings per Share Ratios are 16.31, 20.12 and 23.82. The corresponding 10 year ratios are 20.67, 23.29 and 25.75. The corresponding historical ratios are 13.27, 21.17 and 24.26. The current P/E Ratio is 19.42 based on a stock price of $42.73 and EPS estimate for 2024 of $2.20. The current ratio is below the low ratios for the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap.

I also have Funds from Operations (FFO) data. The 5-year low, median, and high median Price/ Funds from Operations Ratios are 6.92, 8.47 and 9.84. The corresponding 10 year ratios are 8.67, 10.66 and 12.28. The current P/FFO Ratio is 10.22 based on FFO estimate for 2024 of $4.18 and a stock price of $42.73. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I also have Adjusted Funds from Operations (AFFO) data. The 5-year low, median, and high median Price/ Adjusted Funds from Operations Ratios are 7.91, 9.76 and 11.61. The corresponding 10 year ratios are 11.08, 12.75 and 14.25. The current P/AFFO Ratio is 12.10 based on AFFO estimate for 2024 of $3.53 and a stock price of $42.73. The current ratio is between the low and median ratios of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get a Graham Price of $24.49. The 10-year low, median, and high median Price/Graham Price Ratios are 1.31, 1.73 and 1.91. The current P/GP Ratio is 1.74 based on a stock price of $42.73. This ratio is between the median and high ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable but above the median.

I get a 10-year median Price/Book Value per Share Ratio of 2.56. The current ratio is 3.53 based on a stock price of $42.73, Book flue of $2,777M and Book Value per Share of $12.12. The current ratio is 38% above the 10 year median ratios. This stock price testing suggests that the stock price is relatively expensive.

I also have a Book Value per Share estimate for 2024 of $12.30. This implies a ratio of 3.47 based on a stock price of $42.73 and Book Value of $2,819M. This ratio is 36% above the 10 year median ratio. This stock price testing suggests that the stock price is relatively expensive.

I get a 10-year median Price/Cash Flow per Share Ratio of 10.92. The current P/CF Ratio is 10.17 based on Cash Flow per Share estimate for 2024 of $4.20, Cash Flow of $962M, and a stock price of $42.73. The current ratio is 7% below the 10 year median ratios. This stock price testing suggests that the stock price is relatively reasonable and below the median.

I get an historical median dividend yield of 6.02%. The current dividend yield is 4.87% based on dividends of $2.08 and a stock price of $42.73. The current dividend yield is 19% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. However, this stock used to be an Income Trust and these companies have higher yields than corporations.

I get an historical median dividend yield of 5.68%. The current dividend yield is 4.87% based on dividends of $2.08 and a stock price of $42.73. The current dividend yield is 14% below the historical median dividend yield. This stock price testing suggests that the stock price is relatively reasonable but above the median. However, this stock used to be an Income Trust and these companies have higher yields than corporations.

The 10-year median Price/Sales (Revenue) Ratio is 1.79%. The current ratio is 1.42% based on Revenue estimate for 2024 of $6,900M, Revenue per Share of $30.11 and a stock price of $42.73. The current ratio is 20.7% below 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.

Results of stock price testing is that the stock price is probably reasonable, but could be cheap. The dividend yield testing is saying the stock price is reasonable but above the median. The problem with this test is that the company used to be an income trust which can have quite high yields. The P/S Ratio test is saying that the stock price is cheap, and this is a good test. Most of the rest of the testing is saying that the stock price is reasonable and above or below the median.

When I look at analysts’ recommendations, I find Strong Buy (3), Buy (3) and Hold (7). The consensus would be a Buy. The 12 month stock price consensus is $43.46 with a high of $48.00 and low of $38.00. The consensus stock price of $43.46 implies a total return of 6.58% with 1.71% from capital gains and 4.87% from dividends based on a current stock price of $42.73.

Analysts on Stock Chase give this stock 4 buys and one Hold in 2024. There are no negative comments. Stock Chase gives this stock 4 stars out of 5. Aditya Raghunath on Motley Fool says this is an energy stock with a steady and growing dividend. Amy Legate-Wolfe on Motley Fool says even though it is up this year, it is still a buy. The company put out a Press Release about their fourth quarter of 2023. The company put out a Press Release about their second quarter of 2024.

Simply Wall Street via Yahoo Finance reviews this stock. Simply Wall Street gives this stock 3 and one half stars out of 5. Simply Wall Street has 3 warnings of dividend of 4.82% is not well covered by earnings; has a high level of debt; and large one-off items impacting financial results.

Keyera is a midstream energy business that operates primarily out of Alberta. Its primary lines of business consist of the gathering and processing of natural gas in western Canada, the storage, transportation, and liquids blending for natural gas liquids and crude oil, and the marketing of NGLs, iso-octane, and crude oil. Its web site is here Keyera Corp.

The last stock I wrote about was about was Trigon Metals Inc (TSX-TM, OTC-PNTZF) ... learn more. The next stock I will write about will be Cenovus Energy Inc (TSX-CVE, NYSE-CVE) ... learn more on Wednesday, October 30, 2024 around 5 pm. Tomorrow on my other blog I will write about Dividend Increases learn more on Tuesday, October 29, 2024 around 5 pm.

This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.

See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.